Skip to main content

ACR 2023 Podcast - Day3D

Bimekizumab in Active AS_ 5 Year Study INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×